Shiraki Masataka | Department Of Internal Medicine Research Institute And Practice For Involutional Diseases

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
Diagnostic criteria for primary osteoporosis: year 2000 revision
Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteopotosis
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
Nationwide incidence survey of femoral neck fracture in Japan, 1992
Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
Validation of the Japanese Osteoporosis Quality of Life Questionnaire
Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
Bone metabolic marker levels in residents of a rural community in Japan
Effects of 2 Years' Treatment of Osteoporosis with 1α-Hydroxy Vitamin D3 on Bone Mineral Density and Incidence of Fracture : A Placebo-Controlled, Double-Blind Prospective Study
The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
Stability of [Asu1, 7]-Eel Calcitonin and Eel Calcitonin in Vitro and in Vivo
Immunological Stability in Vitro and in Vivo of Eel Calcitonin
Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
1-34 Human Parathyroid Hormone Radioimmunoassay: Properties of Antiserum Against Synthetic 1-34 Human Parathyroid Hormone and Its Clinical Application

もっと見る

スポンサーリンク